Statins and cancer risk
Karp I et al. - Use of lipophilic statins at sufficiently high dose might be associated with a clinically important reduction in the incidence of cancer. Methods- Objective was to investigate the relation between lipophilic statin use and cancer occurrence
- Pts (aged >=45 y) and survivors of acute myocardial infarction were included
- High- and low-dose statin use were defined as at or above (below) the statin-specific target dose, for any of the 4 lipophilic statin medications
- 30,076 pts, including high-dose, low dose, and non users were followed for up to 7 y
Results- Incidence rates of any type of cancer were 13.9, 17.2, and 26.0/1000 person-years in statin high-dose, low-dose, and non-users, respectively
- No significant time-dependence of the effect of statins at either dose was detected
[more...]
|
|
|
